Where is SAGE Therapeutics' corporate headquarters?
SAGE Therapeutics is headquartered at 215 First Street, Cambridge, MA 02142. The main phone number is 617-299-8380.
When was SAGE Therapeutics founded?
SAGE was incorporated in 2010 in the state of Delaware.
How is SAGE Therapeutics' stock traded?
SAGE Therapeutics is traded on the NASDAQ Global Market under the ticker symbol SAGE and its CUSIP number is 78667J 108.
When did SAGE Therapeutics go public?
SAGE Therapeutics’ initial public offering (IPO) occurred on July 18, 2014
When is SAGE Therapeutics' fiscal year-end?
Who is SAGE Therapeutics' transfer agent?
Computershare Trust Company
250 Royall Street, Canton, Massachusetts, 02021
Does SAGE Therapeutics have a direct stock purchase plan?
SAGE Therapeutics does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.
Who are SAGE Therapeutics' independent auditors?
125 High St, Boston, MA 02110
Where can I view SAGE Therapeutics' corporate news releases?
The SAGE Therapeutics press release archives can be accessed at http://investor.sagerx.com/releases.cfm
Where can I view documents that SAGE Therapeutics has filed with the Securities & Exchange Commission (SEC)?
The SAGE Therapeutics SEC filings can be accessed at http://investor.sagerx.com/sec.cfm or www.sec.gov.
Whom should I contact if I have further questions?
You can submit queries to SAGE Therapeutics’ investor relations department by contacting email@example.com or 617-299-8380.